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Abstract
Background: Multimorbidity is a major challenge to health systems globally and disproportionately affects
socioeconomically disadvantaged populations. We examined socioeconomic inequalities in developing
multimorbidity across the lifecourse and investigated the contribution of five behaviour-related risk factors.
Methods: The Twenty-07 study recruited participants aged approximately 15, 35, and 55 years in 1987 and followed
them up over 20 years. The primary outcome was development of multimorbidity (2+ health conditions). The relationship
between five different risk factors (smoking, alcohol consumption, diet, body mass index (BMI), physical activity) and the
development of multimorbidity was assessed. Social patterning in the development of multimorbidity based on two
measures of socioeconomic status (area-based deprivation and household income) was then determined, followed by
investigation of potential mediation by the five risk factors. Multilevel logistic regression models and predictive margins
were used for statistical analyses. Socioeconomic inequalities in multimorbidity were quantified using relative indices of
inequality and attenuation assessed through addition of risk factors.
Results: Multimorbidity prevalence increased markedly in all cohorts over the 20 years. Socioeconomic disadvantage
was associated with increased risk of developing multimorbidity (most vs least deprived areas: odds ratio (OR) 1.46, 95%
confidence interval (CI) 1.26–1.68), and the risk was at least as great when assessed by income (OR 1.53, 95% CI 1.25–1.87)
or when defining multimorbidity as 3+ conditions. Smoking (current vs never OR 1.56, 1.36–1.78), diet (no fruit/vegetable
consumption in previous week vs consumption every day OR 1.57, 95% CI 1.33–1.84), and BMI (morbidly obese vs healthy
weight OR 1.88, 95% CI 1.42–2.49) were strong independent predictors of developing multimorbidity. A dose–response
relationship was observed with number of risk factors and subsequent multimorbidity (3+ risk factors vs none OR 1.91,
95% CI 1.57–2.33). However, the five risk factors combined explained only 40.8% of socioeconomic inequalities in
multimorbidity development.
Conclusions: Preventive measures addressing known risk factors, particularly obesity and smoking, could reduce the
future multimorbidity burden. However, major socioeconomic inequalities in the development of multimorbidity exist
even after taking account of known risk factors. Tackling social determinants of health, including holistic health and
social care, is necessary if the rising burden of multimorbidity in disadvantaged populations is to be redressed.
Keywords: Multimorbidity, Comorbidity, Health behaviour, Risk factors, Health care disparities, Socioeconomic status
* Correspondence: vittal.katikireddi@glasgow.ac.uk
†Equal contributors
1MRC/CSO Social & Public Health Sciences Unit, University of Glasgow, Top
floor, 200 Renfield Street, Glasgow G2 3QB, United Kingdom
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Katikireddi et al. BMC Medicine  (2017) 15:152 
DOI 10.1186/s12916-017-0913-6
Background
Multimorbidity is one of the largest challenges facing
health systems worldwide [1, 2]. Multimorbidity—
usually defined as experiencing two or more chronic
conditions—highlights the limitations of existing
health care systems, which are often ill-suited to meet
the needs of those affected. Traditionally, medical
practice has focussed on diagnosing and treating single
health conditions in isolation [3, 4]. Multimorbidity is
common in the general population [5–8] and increases
with age [5, 9], but it is not limited to the older popu-
lation, since often a greater number of people affected
are aged under 65 years [5, 9].
Socioeconomically disadvantaged populations experi-
ence a greater burden of multimorbidity and are affected
from an earlier age [5, 7]. Prevention-based approaches,
often focussing on well-established risk factors such as
smoking, diet, and physical activity, are being prioritised
by health policy to both improve population health and
address inequalities [10, 11]. However, the importance of
these risk factors for multimorbidity across the
lifecourse and their contribution to socioeconomic
inequalities are unknown. We aimed to describe the
development and social patterning of multimorbidity
over the lifecourse and quantify the contribution of
behaviour-related risk factors.
Methods
Data source
We used data from the West of Scotland Twenty-07 co-
hort study (hereafter ‘Twenty-07’), which was started in
1987 to investigate social processes that produce or
maintain health inequalities. Study details have been
previously published [12, 13]. Twenty-07 employed a
two-stage stratified random sample of respondents from
three cohorts, born in the early 1930s, 1950s and 1970s
(baseline approximate age 15, 35, 55 years) and residing
in the west of Scotland. Comparison with census data
showed that the sample was broadly representative of
the area [14]. Respondents were recruited from 62
sampling units (postcode sectors, average population of
around 5000 people). There were 4510 respondents at
baseline, and there have been four follow-up waves:
1990–1991 (n = 3820); 1995–1997 (n = 2972); 2000–2004
(n = 2661); 2007–2008 (n = 2604). Respondents were
aged approximately 35, 55, and 75 at the final data col-
lection wave, which included 67% of the baseline sample
who were still alive. All cohorts and data collection
waves were used in the analysis, except for the 1970s
cohort at wave 1 (aged 15), as risk factor information was
not collected in a comparable way at this age. We
therefore analyse data on individuals aged across the adult
lifecourse, from 18 to 75 years. Ethical approval was
obtained at each wave from National Health Service
(NHS) and/or University of Glasgow research ethics
committees. Respondents are flagged for routine follow-
up for mortality through the health service registry; 674
had died prior to the final data collection in 2007/2008.
Measures
Outcomes
Multimorbidity is typically characterised by the presence
of two or more chronic conditions [5], but the actual
conditions included vary. We defined chronic conditions
on the basis of those used by Barnett and colleagues in
their landmark study [5], whose work was informed by a
previous systematic review of multimorbidity indices
[15]. Self-reported conditions were coded based on the
Royal College of General Practitioners’ Morbidity classi-
fication [16]. The exact coding process was discussed
and agreed on by two clinically qualified members of the
research team (SVK and SM). Respondents who had two
or more of the 40 relevant conditions were classed as
having multimorbidity. Further details on the diagnostic
coding are provided in Additional file 1: Table S1.
Socioeconomic status
Area-based deprivation categories were calculated
using Carstairs scores for postcode sectors. Carstairs
scores provide an index of deprivation based on census
results for four indicators of socioeconomic status (car
ownership, male unemployment, overcrowding, and
low social class) for residents of each postcode sector
[17]. The seven categories from Twenty-07 were
collapsed into three: least, intermediate, and most
deprived. Household income was used in supplemen-
tary analyses to compare associations with an alterna-
tive measure of socioeconomic status. To make the
income variable comparable across households, it was
weighted for number and age of people living in the
household, using the McClements equivalence scale
[18]. To take account of period effects, tertiles of
income were created separately for each cohort and
wave.
Relative indices of inequality (RIIs) were used to
investigate the potential contribution of risk factors to so-
cioeconomic patterning of multimorbidity [19]. Participants
from each cohort at each wave were ranked from lowest to
highest deprivation score, with the mid-point of each
deprivation category in the cumulative distribution used.
These rank-based measures were then standardised to pro-
duce an index that ranged from zero (the hypothetically
most disadvantaged) to one (the hypothetically most
advantaged) and then regressed on the outcome, with 95%
confidence intervals (CIs) obtained from estimation of the
regression coefficient.
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Risk factors
Risk factors were obtained through surveys adminis-
tered using standardised protocols, with the exception
of body mass index (BMI), which was nurse-measured.
Diet was classified on the basis of frequency of fruit
and vegetable consumption in the 7 days prior to inter-
view into: ate fruit or vegetables every day; ate fruit or
vegetables some days; had not eaten fruit or vegetables.
Exercise was estimated by number of days per week of
activity lasting at least 20 minutes which made the
respondent out of breath or sweaty, categorised into:
none, 1–3, and >3 days. For smoking status, respon-
dents were classified into: never smoker, ex-smoker,
and current smoker. BMI (weight (kg)/height (m2))
utilised standard thresholds: underweight (BMI <18.5),
normal range (BMI 18.5–24.9), overweight (BMI 25.0–
29.9), obese (BMI 30.0–34.9), and morbidly obese
(BMI >34.9). Respondents were asked about alcoholic
drinks consumed in the week prior to interview, and
units of alcohol were calculated based on amount and
type. Two measures of alcohol intake were created:
exceeding existing weekly recommended maximum
guidelines, and exceeding daily recommended
maximum guidelines (binge drinking) in the previous
week. Males exceeded weekly guidelines if they
consumed more than 21 units of alcohol a week, and
exceeded binge drinking guidelines if they consumed
more than 10 units in one session. Equivalent figures
for females were 14 and 7 respectively. Daily units of
alcohol intake were not available for all cohorts at all
waves and were therefore used only in supplementary
analyses. Lastly, a count score was created by adding
up the number of adverse risk factors.
Statistical analyses
The data structure was hierarchical. Multilevel logistic
regression models were used to assess the relationship
between multimorbidity and potential socioeconomic
and health-related risk factors. Models were constructed
in Stata version 13 using three levels: measurement
points (n = 9277), within individuals (n = 3466), and
within sampling units (n = 62), estimated using the adap-
tive Gauss-Hermite quadrature option in the melogit
command.
To understand how multimorbidity prevalence has
changed over time, we modelled prevalence across the
lifecourse by predicting the probability of having multi-
morbidity using our main statistical model described
below. Modelled rather than crude prevalence was
assessed to account for potential bias arising from
attrition.
For the main longitudinal analysis, the outcome at
each wave was modelled based on deprivation and risk
factor predictors from the previous wave, effectively
modelling change over time. For example, multimorbid-
ity outcomes at wave 5 were modelled using deprivation
and risk factor predictors measured at wave 4. The first
set of models examined multimorbidity at waves 2–5
(waves 3–5 for the 1970s cohort) with explanatory vari-
ables age, sex, cohort, and multimorbidity at the previ-
ous wave (waves 1–4, and waves 2–4 for the 1970s
cohort). In the second set of models, deprivation and
each risk factor were added, separately, to Model 1
(Model 1a–g). Risk factors were then added jointly to
determine whether they showed independent associa-
tions with multimorbidity (Model 2).
All models were adjusted for age, sex, cohort, time be-
tween waves, and multimorbidity at the previous data
collection point. Odds ratios (ORs) and 95% CIs were
obtained. The modelling strategy meant that each wave
was conditional on data being available at the previous
wave, hence outcomes at baseline (wave 1 for the 1950s
and 1930s cohort and waves 1 and 2 for the 1970s
cohort) were not modelled. Each participant could be
included in the model up to four times, if they partici-
pated in all five waves (and up to three times for the
1970s cohort).
Interactions between cohort, sex, and age, and with all
risk factor and socioeconomic status variables were
tested using the global Wald test; final models included
significant interactions. There were no significant inter-
actions between risk factors and age, sex, or cohort
(except for income and binge drinking, used in supple-
mentary analyses). However, interactions between sex
and cohort were statistically significant and are included
in all analyses. The best fitting function of age was cubic,
which was included in the model in addition to linear
and quadratic age terms.
To illustrate the results, we present predicted prob-
abilities for developing multimorbidity across the
lifecourse. Stata’s margins command was used, and for
these graphs only, the sample was restricted to those
who were not multimorbid at the prior wave and the
fixed part of the regression models used for prediction.
Separate curves were drawn for each covariate. Lastly,
we investigated how much each risk factor mediated
socioeconomic inequalities in multimorbidity by asses-
sing the percentage change in the coefficient for
deprivation after adding each risk factor, using the
approach of Stringhini et al. [20, 21], i.e. comparing the
coefficients for the magnitude of inequalities across
different regression models.
To minimise potential bias arising from missing data
(see Additional file 1: Table S6 for details on missing
data), we used multiple imputation with chained
equations to address both item and wave missingness.
Imputed data for covariates were not used when there
was attrition from the study (i.e. data were imputed
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when participants temporarily did not engage with the
study but not when no further survey participation oc-
curred). Imputed outcome data were used when covar-
iates were available at the previous wave. We included
auxiliary variables that were correlated with the out-
come (social class and self-rated health) when imput-
ing data. We conducted 24 rounds of multiple
imputation. The regression models and the calculation
of relative indices of inequality are based on the multi-
ply imputed data; a complete case analysis yielded
similar findings (see Additional file 1: Table S10).
Given that there were similar findings between im-
puted and complete case data, predicted probabilities
were calculated using complete case data.
We conducted supplementary analyses to check the
robustness of our findings. As results were similar using
complete case and imputed data, we used complete case
data for the supplementary analyses. To further explore
alcohol intake, guidance on daily recommended units was
used to calculate binge drinking, and this was added as a
risk factor. As a different measure of socioeconomic
status, the associations with household income were
compared to those of area-based deprivation. Given the
potential for death introducing survivorship bias, experi-
encing death or multimorbidity was defined as a second-
ary outcome in sensitivity analyses. A further definition of
the outcome, multimorbidity as three or more conditions,
was also used. We also implemented an alternative medi-
ation modelling approach using Stata’s khb command,
which overcomes some methodological concerns about
traditional approaches to mediation analysis [22]—in
particular, the limitation that regression coefficients from
different logistic regression models should not be compared.
Results
Prevalence of multimorbidity
Baseline prevalence of multimorbidity differed sub-
stantially by age (2.6% at 19 years, 4.2% at 35 years,
and 35.0% at 55 years) (Additional file 1: Table S2).
Multimorbidity prevalence increased substantially over
the 20-year period in all age groups. Figure 1 shows
the predicted prevalence of multimorbidity over the
lifecourse for each cohort, accounting for attrition.
Younger cohorts experienced higher prevalence of
multimorbidity when at the same age as older cohorts.
For example, men born in the 1950s experienced a
59% higher prevalence of multimorbidity at the age of
60 years, compared to men born in the 1930s (59% vs
37% prevalence). At baseline, the most prevalent health
conditions were pain, depression, hypertension, re-
spiratory conditions, and dyspepsia (Additional file 1:
Table S3). As expected, there were large differences by
cohort, with the most common conditions in the
youngest cohort being depression, anxiety, and respira-
tory conditions (Additional file 1: Table S4).
Predictors of developing multimorbidity
Females had higher levels of multimorbidity in all three
cohorts at baseline and throughout the follow-up period.
An interaction between gender and cohort indicated that
gender differences in the development of multimorbidity
increased in the 1970s and 1950s cohorts compared to
the 1930s cohort (multimorbidity for females from the
1970s cohort relative to the 1930s cohort: OR 1.51; 95%
CI 1.11–2.05). The null models and interaction effects
are shown in Additional file 1: Table S5.
Fig. 1 Predicted prevalence of multimorbidity across the lifecourse by cohort and sex
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When added to the regression model separately,
deprivation and all risk factors, except for physical
activity, were significant predictors of multimorbidity
(see Table 1; Model 1). The more risk factors present
within an individual, the higher the odds of developing
multimorbidity; those with three or more risk factors
had almost double the odds (OR 1.91; 95% CI 1.57–
2.33) of developing multimorbidity compared to those
with no risk factors.
Figure 2 shows the relationship between deprivation
and developing multimorbidity; those in the least
deprived areas had a lower predicted probability of
developing multimorbidity than those in the most
deprived areas. The inequalities gap was most appar-
ent between 50 and 70 years (approximately 8.0%
absolute difference in the risk of developing multi-
morbidity over a 5-year time period at 55 years of
age), but was found in younger and older adulthood
as well.
Figure 3 shows age trajectories of developing multi-
morbidity by smoking, BMI, physical activity, diet,
alcohol, and risk factor count. There were clear differ-
ences in probability of developing multimorbidity for
those who were overweight, current or ex-smokers,
those with poor diet, and those reporting no alcohol
consumption. A similar pattern was apparent when
investigating the risk factor count. As with deprivation,
absolute differences between multimorbidity for each
BMI, diet, alcohol, and smoking category were most
apparent in later mid-life, with smaller absolute differ-
ences seen in young and older adulthood. For example,
at age 59, current smokers had a 30% predicted prob-
ability of developing multimorbidity over 5 years com-
pared to 22% for never smokers; whereas at age 23, the
respective probabilities were 11% and 7%.
Lastly, the extent to which the five risk factors attenu-
ated the relationship between area-based deprivation
and multimorbidity was investigated by comparing the
Table 1 Predictors of developing multimorbidity in the Twenty-07 study
Independent variables Model 1a–g: separate models for
each risk factor plus deprivation
Model 2: mutually adjusted
for all risk factors
OR (95% CI) OR (95% CI)
Area-based deprivation Least 1
Intermediate 1.28 (1.12–1.47)*
Most 1.46 (1.26–1.68)*
Smoking Never 1 1
Ex 1.33 (1.16–1.53)* 1.35 (1.18–1.55)*
Current 1.56 (1.36–1.78)* 1.57 (1.37–1.80)*
Alcohol units (recommended weekly units) No excess 1 1
Exceeds 1.07 (0.94–1.23) 1.01 (0.88–1.15)
None/ex 1.50 (1.27–1.77)* 1.49 (1.26–1.76)*
Diet (fruit or vegetable consumption) Everyday 1 1
Some days 1.10 (0.99–1.23) 1.06 (0.95–1.19)
No days 1.57 (1.33–1.84)* 1.45 (1.24–1.71)*
Physical activity 3+ days 1 1
1–3 days 0.94 (0.81–1.09) 0.92 (0.79–1.08)
None 1.02 (0.89–1.16) 0.97 (0.85–1.10)
BMI Healthy 1 1
Overweight 1.21 (1.08–1.36)* 1.26 (1.12–1.41)*
Obese 1.37 (1.17–1.61)* 1.43 (1.21–1.68)*
Morbidly obese 1.88 (1.42–2.49)* 1.98 (1.50–2.62)*
Underweight 1.24 (0.82–12.87) 1.13 (0.74–1.73)
Risk factor count 0 1
1 1.22 (1.04–1.44)*
2 1.51 (1.28–1.79)*
≥3 1.91 (1.57–2.33)*
All models are adjusted for age, age squared, age cubed, sex, cohort, prior multimorbidity, time between waves and sex*cohort interaction. Based on 24 multiply
imputed datasets
*p < 0.05
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magnitude of inequalities before and after adjusting for
different risk factors (Table 2). The RII which summa-
rises the extent of inequality in the development of mul-
timorbidity was 1.74 (95% CI 1.44–2.11). There was
modest attenuation of inequalities when adding risk fac-
tors to the regression models, with smoking (15.4%)
followed by diet (11.9%) making the greatest contribu-
tion to inequalities. Accounting for differences in all five
risk factors resulted in a total of 40.8% attenuation, indi-
cating that the majority of inequalities in the develop-
ment of multimorbidity remained unexplained by these
five risk factors.
Supplementary analyses with household income in-
stead of area deprivation (Additional file 1: Table S7),
daily alcohol (binge drinking) rather than weekly alcohol
units (Additional file 1: Table S8), and different defini-
tions of multimorbidity showed largely similar patterns
of findings. Inequalities by income were slightly greater
than by deprivation, and the risk of developing multi-
morbidity was clearly increased amongst binge drinkers
in contrast to the greatest risk amongst non-drinkers
within the main analysis. Using a combined outcome of
multimorbidity or mortality showed almost identical
findings as those seen in the main analysis, suggesting
that survivorship bias did not account for the findings
(Additional file 1: Table S9). Limiting the main analysis
to complete data also yielded similar findings
(Additional file 1: Table S10). Risk factors were stronger
predictors of multimorbidity when it was defined as be-
ing three or more conditions rather than two (Additional
file 1: Table S11). For example, in the most deprived
group, the OR for developing multimorbidity was 2.04
(95% CI 1.46–2.84) for 3+ chronic conditions compared
to 1.46 (95% CI 1.26–1.68) when 2+ conditions were
used. With multimorbidity defined as three or more
conditions, the RII was 2.52 (95% CI 1.78–3.57) in the
null model, with 33.7% attenuation when adjusting for
all risk factors (Additional file 1: Table S12). Lastly, using
the alternative statistical approach, the Karlson, Holm,
and Breen (KHB) method, to investigate the mediation
of five behaviour-related risk factors on socioeconomic
inequalities in multimorbidity led to similar results
(Additional file 1: Table S13).
Discussion
Socioeconomic status predicts the development of
multimorbidity throughout the adult lifecourse, with
inequalities greatest between 50 and 70 years. Modifi-
able risk factors (such as smoking, lack of physical ac-
tivity, and poor diet) for several chronic conditions are
important predictors of developing multimorbidity.
While these risk factors appear to partially mediate the
relationship between deprivation and multimorbidity,
the majority of the relationship between deprivation
and developing multimorbidity remains unexplained.
Efforts to reduce these known risk factors at any
point across the lifecourse could contribute to address-
ing the growing burden of multimorbidity, with the
greatest potential impact when changing behaviour
before age 50. However, behaviour-related risk factors
only mediate the association between deprivation and
multimorbidity to a limited extent; most of this associ-
ation is unexplained. It is essential to also focus
attention on addressing the underlying causes of
Fig. 2 The independent contribution of area deprivation to the predicted probability of developing multimorbidity over a 5-year period in the
Twenty-07 study (Adjusted for age, age squared, age cubed, sex, cohort, previous multimorbidity, time between waves, and cohort*sex interaction.
The above does not include risk factors within the statistical model)
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deprivation to reduce health inequalities [23]. The
most socioeconomically disadvantaged experience the
greatest burden of multimorbidity, and in addition to
the imperative to tackle such inequality, health systems
also need to be responsive to it. Effective health care
that is based on a collaborative, comprehensive,
patient-centred system is required to deal with such
patient complexity [24–26]. A starting point is univer-
sal coverage of health care, especially primary care.
However, even in such systems, the inverse care law
Fig. 3 The independent contribution of risk factors to the predicted probability of developing multimorbidity over a 5-year period in the Twenty-07
study (Adjusted for age, age squared, age cubed, sex, cohort, previous multimorbidity, time between waves, and cohort*sex interaction)
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persists, affecting patients of low socioeconomic status
with complex multimorbidity the most [27, 28].
Our study has several important strengths. We inves-
tigate a well-characterised longitudinal cohort designed
to cover the entire adult lifecourse. Furthermore, the
sample is representative of the general population, and
we collected social variables in a standardised manner.
However, some limitations should be noted. First, mul-
timorbidity was defined on the basis of self-reported
health conditions, which may lead to bias in outcome
ascertainment [29]. However, health conditions were
coded using standardised criteria by trained health
professionals. Second, most risk factor information was
self-reported—likely to be particularly problematic for
physical activity. A related issue is that the measures
capture behaviour at a particular time point, with
reverse causation likely to explain the findings related
to alcohol. In addition, the measures of diet and phys-
ical activity only captured specific aspects of these
behaviour-related risk factors. Aspects of diet, other
than fruit and vegetable consumption, which may be
associated with development of multimorbidity (e.g.
salt and saturated fat consumption) could not be in-
cluded. Likewise, further details on physical activity
(e.g. type of activity, whether it was work or leisure re-
lated, and more information on how much activity)
could not be included. Third, there are other poten-
tially important dimensions of socioeconomic position
which we have not been able to investigate; future
investigation may provide a greater level of under-
standing and afford opportunities for intervention. For
example, low education has been linked to multimor-
bidity [30] and is also closely linked to health literacy,
thereby highlighting a potential target for intervening
to influence health behaviour. Fourth, all cohorts
experience attrition, although given the diverse socio-
economic population studied in the Twenty-07 study,
this is relatively modest. Fifth, our variables have some
missing data, which we addressed through multiple
imputation.
Conclusions
Our study demonstrates the existence of substantial socio-
economic inequalities in the development of multimorbid-
ity throughout the adult lifecourse. While common risk
factors predispose to the development of multimorbidity,
a key finding of this study is that the relationship between
deprivation and the development of multimorbidity is only
partially mediated by lifestyle factors. Future research is
required to identify other factors that mediate the
relationship between deprivation and multimorbidity.
Furthermore, there is a need for further research to
distinguish the relative importance of mental and physical
health conditions [31] as well as investigate combinations
of specific health conditions in greater detail [32, 33].
Irrespective of the biological pathways, policies and
interventions focussing on the social determinants of
health may be the key to reducing the prevalence and
severity of multimorbidity. Social determinants include
access to high-quality health care, with the continuing
existence of the ‘inverse care law’ likely contributing to
excess multimorbidity in deprived areas. A recent
exploratory cluster randomised controlled trial which
supported general practitioners and practice nurses
working in deprived areas to deliver holistic, person-
centred care to patients with multimorbidity led to cost-
effective improvement in wellbeing [34, 35]. Beyond this,
a focus on addressing non-health sector determinants,
including income, employment, housing, and the social
and physical environment, is necessary [36–38].
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